Institutional Ownership
Radiopharm Theranostics Ltd
CUSIP 75041J101SPONSORED ADSRADXQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
9.1%
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Jan 8, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 8, 2026 | Regal Partners Holdings Pty Limited | 13G | 9.1% | 320.69M | SEC |
| 2 | Jul 23, 2025 | Regal Funds Management Pty Limited | 13G | 7.3% | 172.63M | SEC |
| 3 | May 12, 2025 | Regal Funds Management Pty Limited | 13G | 9.0% | 210.72M | SEC |
| 4 | Jan 29, 2025 | Regal Funds Management Pty Limited | 13G | 8.0% | 175.08M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Silverarc Capital Management, LLC | 187.4K | $805.8K |
| 2 | Stonepine Capital Management, LLC | 51.00M | $739.0K |
| 3 | Hsbc Holdings PLC | 61.4K | $264.5K |
| 4 | Regal Partners Ltd | 40.1K | $172.6K |
| 5 | Pnc Financial Services Group, Inc. | 16.0K | $68.8K |
| 6 | Ubs Group AG | 3.0K | $12.9K |
| 7 | Rhumbline Advisers | 121 | $519 |